Skip to main content

Table 1 Clinical characteristics of the three TIR subgroups in T1D patients

From: Metabolomics analysis of serum and urine in type 1 diabetes patients with different time in range derived from continuous glucose monitoring

Variable

Overall

(N = 85)

TIR-L

(N = 21)

TIR-M

(N = 50)

TIR-H

(N = 14)

P-value

(3 subgroup)

P-value

(TIR-L vs. TIR-H)

Gender (F/M)

55/30

13/8

33/17

9/5

0.950

1.000

Age (y.o)

35.00(18.00)

30.00(25.50)

36.00(14.00)

35.50(32.75)

0.323

0.152

Age at onset (y.o)

27.96(19.64)

25.71(26.71)

26.48(19.81)

33.24(27.77)

0.056

0.043

Duration of T1D (years)

6.60(10.61)

8.85(9.45)

8.22(12.33)

3.40(5.23)

0.009

0.024

BMI (kg/m2)

21.16(3.65)

21.20(5.17)

21.10(4.34)

21.37(3.50)

0.584

0.602

SBP (mmHg)

114.00(21.00)

113.00(20.00)

111.50(21.25)

118.50(28.25)

0.897

0.625

DBP (mmHg)

70.00(15.50)

70.00(12.50)

70.00(18.00)

68.00(12.25)

0.713

0.354

TC (mmol/L)

4.63(1.14)

4.47(1.47)

4.67(1.26)

4.69(0.77)

0.874

0.893

TG (mmol/L)

0.54(0.30)

0.56(0.22)

0.55(0.34)

0.48(0.28)

0.474

0.138

HDL-C (mmol/L)

1.57(0.69)

1.46(0.72)

1.57(0.69)

1.70(0.69)

0.714

0.490

LDL-C (mmol/L)

2.43(0.99)

2.46(0.94)

2.42(1.03)

2.35(0.74)

0.703

0.400

ALT (U/L)

15.00(8.00)

16.00(7.00)

15.00(8.25)

18.00(16.00)

0.497

0.266

Cr (umol/L)

59.70(16.00)

59.00(13.50)

61.50(17.75)

57.00(13.85)

0.459

0.555

eGFR (ml/min/1.73m2)

167.19(61.69)

176.12(84.90)

159.23(65.21)

168.92(49.61)

0.500

0.459

HbA1c (%)

7.40(1.75)

9.00(1.70)

7.15(1.20)

6.80(1.40)

 < 0.001

 < 0.001

FBG (mmol/L)

8.80(6.50)

12.50(6.20)

8.10(6.98)

7.35(3.38)

0.002

0.001

1 h-BG (mmol/L)

16.60(8.25)

19.70(5.80)

16.50(10.00)

13.80(4.93)

0.001

 < 0.001

2 h-BG (mmol/L)

19.50(9.95)

23.40(8.60)

19.15(10.63)

16.25(10.35)

0.011

0.006

FCP (ng/mL)

0.00(0.29)

0.00(0.20)

0.00(0.15)

0.34(0.46)

0.015

0.025

Family history, N(%)

28(32.9)

7(33.3)

17(34.0)

4(28.6)

1.000

1.000

Diabetic complications, N(%)

13(15.3)

5(23.8)

7(14.0)

1(7.1)

0.401

0.366

Smoke, N(%)

10(11.8)

5(23.8)

4(8.0)

1(7.1)

0.189

0.366

Drinking alcohol, N(%)

17(20.0)

5(23.8)

10(20.0)

2(14.3)

0.866

0.676

Regular exercise, N(%)

17/8/60

5/3/13

9/2/39

3/3/8

0.185

0.894

Insulin pump, N(%)

21(24.7)

4(19.0)

14(28.0)

3(21.4)

0.779

1.000

Daily Insulin dose (U/d)

34.00(16.50)

36.00(15.03)

34.08(19.45)

26.50(13.00)

0.004

0.003

Average daily Insulin dose (U/kg/d)

0.59(0.23)

0.63(0.21)

0.58(0.24)

0.50(0.24)

0.016

0.016

Oral medications

 AGI, N(%)

16(18.8)

4(19.0)

8(16.0)

4(28.6)

0.587

0.685

 Metformin, N(%)

20(23.5)

7(33.3)

10(20.0)

3(21.4)

0.459

0.704

  1. Bold text represents P value < 0.05
  2. n (%); Median (IQR); Fisher exact test; Kruskal–Wallis H test; Mann-Whitey U test
  3. TIR, time in range; TIR-H, high TIR group; TIR-M, moderate TIR group; TIR-L, low TIR group; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; ALT, alanine transaminase; Cr, creatine; eGFR, estimated glomerular filtration rate; HbA1c, glycosylated hemoglobin; FBG, fasting blood glucose; FCP, fasting C- peptide; AGI, α-glycosidase inhibitor